Live News Categoriesequity

Jiangsu Hengrui Pharmaceuticals Co.,Ltd (1276.HK) News

Follow Jiangsu Hengrui Pharmaceuticals Co.,Ltd (1276.HK) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol 1276.HK Asset equity Sector Markets 90 days 1 Last 47.44 Updated Oct 16, 2026, 11:58 AM UTC Open live news feed

L BRIEF — BlackRock's Long Position In H — Shares Of Jiangsu Hengrui Pharmaceuticals Decreases To 5.72% On Oct 13 From 6.33%, HKEX Shows Oct 16 (Reuters) — HKEX: Blackrock Inc's Long Position In H-shares Of Jiangsu Hengrui Pharmaceuticals Decreases To 5.72% On Oct 13 From 6.33% Further company coverage: (reuters.briefs@thomsonreuters.com;) EQUITY | Oct 16, 2026, 11:58 AM UTC